Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – tuberous sclerosis complex
Keywords: ANALYSIS OF CLINICAL; AUTISM; BIOMARKERS; BLOOD-BASED; BLOOD-DERIVED BIOMARKERS; DEVELOPMENTAL DELAY; DRUG-RESISTANCE; DRUG-RESISTANT EPILEPSY; EPILEPSY; EPILEPSY-RELATED COMORBIDITIES; EPILEPTOGENESIS; MOLECULAR; NEUROIMAGING; PRE-SEIZURE TREATMENT; RISK FACTORS; THERAPEUTIC TARGETS
Document Type: Research Article
Affiliations: 1: Vrije Universiteit Brussel, Belgium 2: Medical University of Warsaw, Poland 3: Katholieke Universiteit Leuven, Belgium 4: Brigham And Womens Hospital, Inc., UK 5: Universitair Medisch Centrum Utrecht, Netherlands 6: Academisch Medisch Centrum bij Universiteit van Amsterdam, Netherlands 7: Instytut Pomnik- Centrum Zdrowia Dziecka, Poland
Publication date: 01 April 2019
Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.
- Subscribe to this Title
- Terms & Conditions
- Disseminating research in Impact
- Information about Impact
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content